Plandai Biotechnology, Inc. engages in the production of botanical extracts for the nutriceutical and pharmaceutical industries. The firm through its subsidiary, Global Energy Solutions, Ltd. focuses on the farming of whole fruits, vegetables and live plant material and the production of proprietary functional foods and botanical extracts for the health and wellness industry. The company was founded on November 30, 1942 and is headquartered in London, the United Kingdom.
Company profile
Ticker
PLPL
Exchange
Website
CEO
Roger Baylis-Duffield
Employees
Location
Fiscal year end
Sector
Industry (SIC)
Former names
Diamond Ranch Foods, Ltd., NEW
SEC CIK
Corporate docs
IRS number
453642179
PLPL stock data
Latest filings (excl ownership)
10-Q
2017 Q1
Quarterly report
20 Mar 23
10-K
2016 FY
Annual report
16 Mar 23
15-12G
Securities registration termination
31 Jan 17
NT 10-K
Notice of late annual filing
28 Sep 16
8-K
Amendments to Articles of Incorporation or Bylaws
21 Sep 16
10-Q
2016 Q3
Quarterly report
17 Aug 16
10-Q
2016 Q2
Quarterly report
12 Aug 16
10-Q
2016 Q1
Quarterly report
29 Jul 16
10-K
2015 FY
Annual report
30 Jun 16
UPLOAD
Letter from SEC
9 Jun 16
Latest ownership filings
SC 13G/A
EMA Financial, LLC
15 Feb 22
SC 13G/A
EMA Financial, LLC
27 Jan 21
SC 13G
ADAR BAYS LLC
21 Jan 21
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G/A
Plandai Biotechnology, Inc.
15 Feb 19
SC 13G
Plandai Biotechnology, Inc.
14 Feb 18
SC 13G/A
Plandai Biotechnology, Inc.
24 Apr 17
SC 13G/A
Plandai Biotechnology, Inc.
1 Feb 17
SC 13G
Plandai Biotechnology, Inc.
27 Sep 16
SC 13G
Plandai Biotechnology, Inc.
1 Sep 16
Financial summary
| Quarter (USD) | Sep 16 | Jun 16 | Mar 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Jun 16 | Jun 15 | Jun 14 | Jun 13 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q4 2021
7.5% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 284.00 k |
| Total shares | 578.20 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| EMA Financial | 300.93 mm | $90.00 k |
| Adar Bays | 277.27 mm | $194.00 k |
Press releases
ByoPlanet's bCOOL(TM) Cooling Technology Enhances Performance and Recovery for Major League and College Teams
25 May 23
ByoPlanet and Merck Animal Health Announce Partnership with USEF
23 May 23
Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health
19 May 23
Following Completed Share Exchange Agreement with ByoPlanet, Plandai Announces Material Rebranding to Disinfectant Industry Focus
18 May 23
ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology
17 May 23